Trial intelligence / Profile preview

Karika Syrup for Thrombocytopenia

NCT05563064Phase 3Unknown

Sponsor
Shifa-ul-Mulk Memorial Hospital
Start
Jan 2021
Primary completion
Jan 2023
Countries
1
01

Overview

A Phase 3 trial of Karika in Thrombocytopenia, sponsored by Shifa-ul-Mulk Memorial Hospital. Status: unknown.

02

Drugs

Karika
03

Conditions

Thrombocytopenia

Beyond the preview

Go deeper on NCT05563064.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05563064.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call